Factors Influencing ADME Properties of Drugs: Advances and Applications (Part I)

Zhang, S.Q.; Chen, F. Absorption, disposition and pharmacokinetic properties of novel therapeutic modalities. Curr. Drug Metab., 2020, 21(12), 912.
[http://dx.doi.org/10.2174/138920022112201207105752]

Zhang, S.Q.; Chen, F. Absorption, disposition and pharmacokinetic properties of novel therapeutic modalities (Part II). Curr. Drug Metab., 2021, 22(1), 3-4.
[http://dx.doi.org/10.2174/138920022201210302091521]

Abdul-Aziz, M.H.; Alffenaar, J.C.; Bassetti, M.; Bracht, H.; Dimopoulos, G.; Marriott, D.; Neely, M.N.; Paiva, J.A.; Pea, F.; Sjovall, F.; Timsit, J.F.; Udy, A.A.; Wicha, S.G.; Zeitlinger, M.; De Waele, J.J.; Roberts, J.A. Infection section of European society of intensive care medicine (ESICM); pharmacokinetic/pharmacodynamic and critically Ill patient study groups of European society of clinical microbiology and infectious diseases (ESCMID); infectious diseases group of international association of therapeutic drug monitoring and clinical toxicology (IATDMCT); infections in the ICU and sepsis working group of international society of antimicrobial chemotherapy (ISAC). Antimicrobial therapeutic drug monitoring in critically ill adult patients: A position paper. Intens. Care Med., 2020, 46(6), 1127-1153.
[http://dx.doi.org/10.1007/s00134-020-06050-1]

Liu, Y.; Ge, X.H.; Guo, H.L.; Chen, F.; Zhang, Y.; Xu, J.; Ji, X.; Miao, H.J. A systematic review of linezolid pharmacokinetics/pharmacodynamics in patients undergoing continuous renal replacement therapy: Does one size fit all? Curr. Drug Metab., 2023, 24(1), 70-77.
[http://dx.doi.org/10.2174/1389200224666221228144117]

Telles, J.P.; Morales, R., Jr; Yamada, C.H.; Marins, T.A.; D’Amaro Juodinis, V.; Sztajnbok, J.; Silva, M., Jr; Bassetti, B.R.; Albiero, J.; Tuon, F.F. Optimization of antimicrobial stewardship programs using therapeutic drug monitoring and pharmacokinetics-pharmacodynamics protocols: A cost-benefit review. Ther. Drug Monit., 2023, 45(2), 200-208.

He, X.; Liu, Y.; Gong, X.; Wang, L.; Chen, F. Meropenem for the pharmacological treatment of severe infections in critically ill pediatric patients: Breakthrough standard treatment strategies based on PK/PD. Curr. Drug Metab., 2023, 24(1), 5-15.
[http://dx.doi.org/10.2174/1389200224666230325121729]

Wang, T.; Liu, J.; Luo, X.; Hu, L.; Lu, H. Functional metabolomics innovates therapeutic discovery of traditional Chinese medicine derived functional compounds. Pharmacol. Ther., 2021, 224, 107824.
[http://dx.doi.org/10.1016/j.pharmthera.2021.107824]

Wang, P.; Li, K.; Tao, Y.; Li, D.; Zhang, Y.; Xu, H.; Yang, H. TCM-ADMEpred: A novel strategy for poly-pharmacokinetics prediction of traditional Chinese medicine based on single constituent pharmacokinetics, structural similarity, and mathematical modeling. J. Ethnopharmacol., 2019, 236, 277-287.
[http://dx.doi.org/10.1016/j.jep.2018.07.008]

Wang, C.Y.; Hu, Y.H.; Sun, Z.X. Hepatic effect of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucoside, the signature component of traditional Chinese medicine Heshouwu: Advances and prospects. Curr. Drug Metab., 2023, 24(1), 16-27.
[http://dx.doi.org/10.2174/1389200224666230223144826]

Fugh-Berman, A. Herb-drug interactions. Lancet, 2000, 355(9198), 134-138.
[http://dx.doi.org/10.1016/S0140-6736(99)06457-0]

Cheng, W.; Xia, K.; Wu, S.; Li, Y. Herb-drug interactions and their impact on pharmacokinetics: An update. Curr. Drug Metab., 2023, 24(1), 28-69.
[http://dx.doi.org/10.2174/1389200224666230116113240]